August 5, 2025

NewAmsterdam Pharma (NAMS): Unveiling a 91.71% Potential Upside with Strong Buy Ratings

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is capturing the attention of investors with its promising growth trajectory in the healthcare sector, specifically within the biotechnology industry. Headquartered in Naarden, the..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 254% Potential Upside

Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage biotech firm headquartered in Waltham, Massachusetts, is drawing significant attention in the healthcare sector with its innovative approach to treating neuromuscular diseases. The..

PACS Group, Inc. (PACS) Stock Analysis: A Healthcare Giant with 177% Upside Potential

PACS Group, Inc. (NASDAQ: PACS), a key player in the healthcare sector, has been capturing significant investor attention due to its robust growth prospects and compelling valuation metrics. Specializing in..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 51.62% Potential Upside for Investors

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector with its robust growth potential and promising market position. Headquartered in Eagle, Idaho, this company has carved..

Organon & Co. (OGN) Stock Analysis: Unlocking a Potential 37.88% Upside for Investors

Investors with an eye on the healthcare sector might find Organon & Co. (OGN) an intriguing opportunity as the company’s stock presents a potential upside of 37.88% according to analyst..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 26% Potential Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, specifically within the medical devices industry, has captured the attention of investors with its recent stock performance..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Buy Ratings Signal 24% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is making waves in the biopharmaceutical sector, capturing investor attention with a robust growth trajectory and an impressive forecasted upside. With a market capitalization of..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 178% Potential Upside with Innovative Cardiorenal Solutions

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to tackling cardiorenal diseases. Headquartered in Radnor, Pennsylvania,..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Uncovering a 31.51% Potential Upside in the Biotech Sector

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is capturing investor attention with its promising prospects in the biotechnology industry. With a market capitalization of $2.59 billion, this Foster City, California-based company is..

Innoviva, Inc. (INVA) Stock Analysis: A Potential 116.96% Upside with Robust Revenue Growth

Innoviva, Inc. (NASDAQ: INVA) operates within the dynamic healthcare sector, focusing on biotechnology, where it engages in the development and commercialization of a broad range of pharmaceutical products. Headquartered in..

Disc Medicine, Inc. (IRON): Analyst Consensus Highlights 62.65% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON) is capturing the attention of investors with its promising growth potential and a robust pipeline of treatments aimed at serious hematologic conditions. As a clinical-stage..

Arcutis Biotherapeutics, Inc. (ARQT)

⚠️ No article content returned.

..

Immunovant, Inc. (IMVT) Stock Analysis: Understanding the 158.81% Potential Upside in Biotech

Immunovant, Inc. (NASDAQ: IMVT), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline and remarkable potential upside. With a market capitalization of..

Evolent Health, Inc (EVH) Stock Analysis: Navigating a Potential 56.68% Upside in Healthcare Innovation

Evolent Health, Inc. (NASDAQ: EVH), a prominent player in the healthcare sector, is making waves in the Health Information Services industry with its innovative approaches to specialty care management. Based..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Analysts Predict a 48.88% Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS), a key player in the healthcare sector, specifically within the medical instruments and supplies industry, has garnered significant attention from investors due to its robust..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 50% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, specifically in the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors seeking significant upside..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Navigating the Highs of Revenue Growth Amidst Market Challenges

Ascentage Pharma Group International (AAPG), a key player in the biotechnology sector, is gaining attention with its remarkable revenue growth of 97.90%. Specializing in developing therapies for cancer, chronic hepatitis..

Kymera Therapeutics (KYMR) Stock Analysis: A Biotech Powerhouse with 38% Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a pioneering name in the biotechnology industry, is making waves with its promising portfolio of small molecule therapeutics. Specializing in leveraging the body’s natural protein..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 95% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the medical devices industry, is capturing investor attention with its impressive potential upside of 95.53%, according to analyst forecasts. The company, headquartered..

Mesoblast Limited (MESO): Investor Outlook on a Biotech with Promising Upside Potential

Mesoblast Limited (MESO), a key player in the biotechnology sector, has been turning heads with its compelling growth potential, notably boasting a substantial 74.98% potential upside, according to recent analyst..

Search

Funds

August 5, 2025

Search

Funds

August 5, 2025

FTSE 100

Funds